Sumit Chanda

Last updated

Sumit K. Chanda is an American research scientist who works on viral and immunological human diseases. [1] He also led the team that built and deployed Metascape for the analysis of omics data. [2] This tool has been cited over 7,600 times since its inception in 2019. [3]

Contents

Early life and education

Chanda earned his B.Sc. in biology at Cornell University and his Ph.D. in molecular pharmacology at Stanford University. He completed his postdoctoral training at the Genomics Institute of the Novartis Research Foundation, [4] where he pioneered high-throughput approaches for target identification and validation that enabled preclinical development of novel therapeutics. [5]

Career

In 2014, Chanda, along with Bin Zhou, Yingyao Zhou, Max Chang, Lars Pache and Chris Benner created a free gene annotation and analysis resource called Metascape. [6]

He returned to academic research at Sanford Burnham Prebys Medical Discovery Institute in 2007, where he became director of their Immunity and Pathogenesis program, [7] and joined the Immunology and Microbiology Department at the Scripps Research Institute and Calibr as professor in 2021. [8]

Chanda developed and applied large-scale systems-based approaches to identify host factors critical for viral replication, including influenza, SARS-CoV-2, [9] flaviviruses and HIV-1. His team deployed high-throughput technologies for the discovery of antiviral therapies in response to the COVID-19 pandemic [10] and discovered a novel class of latency reversal agents for an HIV-1 cure (3).

Chanda leads several large, multi-institutional collaborative efforts including the Center for Antiviral Medicines (CAMPP), [11] which is a part of the NIAID Antiviral Drug Discovery (AViDD) network, as well as the Reversing Immune Dysfunction for HIV-1 Eradication Program (RID-HIV), which is a member of the National Institutes of Health's Martin Delaney Collaboratories for HIV Cure Research (MDC) program. [12]

Publications

References

  1. Chanda, Sumit (2023-02-21). "How can we prepare for the next pandemic? Sumit Chanda Podcast Highlights" (Interview). Scripps Research . Retrieved 2023-09-22 via YouTube.
  2. Zhou, Yingyao; Zhou, Bin; Pache, Lars; Chang, Max; Khodabakhshi, Alireza Hadj; Tanaseichuk, Olga; Benner, Christopher; Chanda, Sumit K. (2019-04-03). "Metascape provides a biologist-oriented resource for the analysis of systems-level datasets". Nature Communications. 10 (1): 1523. Bibcode:2019NatCo..10.1523Z. doi: 10.1038/s41467-019-09234-6 . ISSN   2041-1723. PMC   6447622 . PMID   30944313.
  3. "Metascape". metascape.org. Retrieved 2025-02-26.
  4. "Novartis Institutes for BioMedical Research". Novartis . Retrieved 2023-09-22.
  5. "Sumit K. Chanda Inventions, Patents and Patent Applications - Justia Patents Search". Justia . Retrieved 2023-09-22.
  6. Metascape. "The Brief History of Metascape Since 2014 | Metascape Blog" . Retrieved 2023-09-28.
  7. Weintraub, Arlene (Apr 20, 2020). "COVID-19: New animal data back up Gilead's remdesivir as other treatment candidates emerge". Fierce Biotech.
  8. "Sumit Chanda". Scripps Research . Retrieved 2023-09-22.
  9. "Meet the authors: Laura Martin-Sancho and Sumit K. Chanda" (PDF). Molecular Cell . June 17, 2021.
  10. "High-throughput screening reveals 21 drugs with activity against COVID-19" (Press release). Retrieved 2023-09-22 via Drug Target Review.
  11. "NIAID Announces Antiviral Drug Development Awards". National Institute of Allergy and Infectious Diseases (Press release). 2022-05-18. Retrieved 2023-09-22.
  12. Chanda, Sumit. "Sumit Chanda - From HIV to Covid-19 (EP.01)". Model Medicines (Interview). Retrieved 2023-09-22.